Kalaris Therapeutics, Inc. (KLRS)
9.13
-1.29
(-12.38%)
USD |
NASDAQ |
Dec 19, 16:00
9.41
+0.28
(+3.07%)
After-Hours: 04:56
Kalaris Therapeutics Market Cap: 170.75M for Dec. 19, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CEL-SCI Corp. | 14.90M |
| AIM ImmunoTech, Inc. | 1.085M |
| IGC Pharma, Inc. | 27.86M |
| NovaBay Pharmaceuticals, Inc. | 667.86M |
| Protalix Biotherapeutics, Inc. | 139.13M |
Market Cap Related Metrics
| Price to Book Value | 4.079 |
| Price | 9.13 |
| Earnings Yield | -81.02% |